伴侣动物诊断市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球伴侣动物诊断市场规模达24亿美元，预计2034年将以9.3%的复合年增长率成长，达到58亿美元。推动这一增长的因素包括全球宠物主人数量的增长、人们对宠物陪伴的偏好日益增长，以及动物慢性病和传染病诊断需求的激增。随着宠物照护逐渐成为家庭生活不可或缺的一部分，兽医服务支出持续攀升。宠物主人越来越多地将动物视为家庭成员，因此会定期进行健康检查、预防性护理和及时诊断。这种文化转变促使人们更加关注动物健康，从而显着推高了对先进诊断工具和服务的需求。

市场扩张也得益于人们对人畜共通传染病认知的不断提高，以及早期诊断对于避免併发症的重要性。兽医专业人员越来越依赖诊断来评估器官功能障碍、代谢问题和感染等情况，这进一步推动了该行业的发展。此外，技术进步正在重塑产业格局，使快速、准确、微创的诊断技术成为可能。兽医诊断领域的创新缩短了诊断週期，并使其与治疗策略更好地融合，使诊断成为动物保健的重要组成部分。随着全球兽医护理基础设施的加强，对诊断产品和服务的需求预计将保持上升趋势。

就产品细分而言，市场分为仪器与耗材两大类。 2024年，耗材市场占据主导地位，价值达20亿美元。这种主导地位源自于试剂、检测试剂盒、玻片和试管等耗材在每个诊断过程中都扮演着至关重要的角色。与仪器不同，耗材是每次检测都需要的，因此会产生重复购买，并带来稳定的市场收入。随着诊所和医院动物检测频率的增加，预计耗材需求也将随之增加。定期体检和预防性筛检的趋势进一步推动了耗材的使用。此外，随着越来越多的诊断程序转向快速诊断和即时诊断，专为一次性应用量身定制的耗材正成为标准配置，从而推动该细分市场的成长。

按应用分析，细菌学领域在2024年成为领先类别，预计2034年将达到24亿美元。该领域在检测伴侣动物的细菌感染方面发挥着至关重要的作用，而细菌感染在各种健康状况下都很常见。从皮肤和泌尿道感染到呼吸道和胃肠道疾病，准确识别细菌病原体对于治疗计划至关重要。细菌学诊断技术的现代进步，包括改进的培养方法和快速抗原检测，显着提高了诊断效率。此类技术在中心实验室和即时医疗机构的日益普及，巩固了细菌学在诊断领域的地位。

按动物类型划分，犬类在2024年以53.7%的市占率占据市场主导地位。这种主导地位归因于犬作为伴侣动物的广泛饲养，以及对其医疗保健的投资不断增加。犬类慢性病的发生率不断上升，导致糖尿病、肾臟病、关节炎和心血管疾病等疾病的诊断检测需求增加。常规诊断已成为犬类疾病管理的关键，进一步推动了该领域的需求。

就最终用途而言，诊断实验室在2024年占据了最大的市场份额，预计2025年至2034年期间的复合年增长率将达到9.1%。这些实验室配备了高端诊断系统，并配备训练有素的专业人员，能够有效地处理大量样本。它们能够提供准确、快速和全面的结果，成为寻求可靠诊断支援的兽医的首选。随着宠物主人数量的增加，以及越来越多的人选择定期为宠物进行健康评估，诊断实验室的角色将变得更加重要。

从区域来看，北美引领全球伴侣动物诊断市场，2024 年市场价值达 10 亿美元，预计到 2034 年将达到 23 亿美元，复合年增长率为 8.8%。光是美国一国，2024 年的市场价值就达 8.933 亿美元。高宠物拥有率和尖端诊断服务的普及推动了该地区的需求。此外，强大的兽医医疗保健网络和不断增长的动物保健消费者支出也持续支撑北美市场的表现。

竞争格局由多家全球和区域性企业主导，爱德士实验室 (IDEXX Laboratories)、赛默飞世尔科技 (Thermo Fisher Scientific)、硕腾 (Zoetis) 和赫斯卡 (Heska Corporation) 等主要公司合计占据全球约 60% 至 65% 的市场份额。这些公司凭藉着广泛的产品组合、广泛的地域覆盖以及持续的研发投入，保持领先地位。同时，许多本地企业也透过提供经济高效的诊断解决方案，并透过合作、收购和新产品开发来拓展产品线，加剧了竞争。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
  • 供应商格局
  • 每个阶段的增值
  • 影响价值链的因素
• 产业衝击力
  • 成长动力
    • 收养宠物的趋势日益增长
    • 传染病和人畜共通传染病的盛行率上升
    • 有利的政府倡议
    • 伴随诊断的进展
    • 宠物保险的普及率不断提高
  • 产业陷阱与挑战
    • 动物试验成本过高
    • 兽医护理自付费用低
  • 市场机会
    • 技术进步和即时诊断分子工具
• 成长潜力分析
• 监管格局
• 技术格局
  • 当前的技术趋势
  • 新兴技术
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係与协作
  • 新产品发布
  • 扩张计划

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 耗材
• 仪器

第六章：市场估计与预测：按技术，2021 - 2034 年

• 主要趋势
• 临床生物化学
  • 血糖监测
  • 血气和电解质分析
  • 其他临床生化检查
• 免疫诊断
  • 横向流动试验
  • 酵素连结免疫吸附试验
  • 免疫分析仪
  • 其他免疫诊断测试
• 分子诊断
  • 聚合酶连锁反应
  • 微阵列
  • 其他分子诊断测试
• 血液学
• 尿液分析
• 其他技术

第七章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 细菌学
• 病理
• 寄生虫学
• 其他应用

第八章：市场估计与预测：按动物类型，2021 - 2034 年

• 主要趋势
• 狗
• 猫
• 马匹
• 其他动物类型

第九章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 兽医医院和诊所
• 诊断实验室
• 居家照护环境
• 其他最终用途

第十章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 波兰
  • 荷兰
  • 瑞典
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 菲律宾
  • 泰国
  • 印尼
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 哥伦比亚
  • 秘鲁
  • 智利
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 土耳其
  • 埃及
  • 以色列

第 11 章：公司简介

• bioMerieux
• BioNote
• Bio-Rad Laboratories
• Boehringer Ingelheim International
• Heska Corporation (Mars)
• Idexx laboratories
• KogeneBiotech
• Median Diagnostics
• Neogen Corporation
• Randox
• Thermo Fischer Scientific
• Virbac
• VetAll Laboratories
• Qiagen
• Zoetis

The Global Companion Animal Diagnostics Market was valued at USD 2.4 billion in 2024 and is estimated to grow at a CAGR of 9.3% to reach USD 5.8 billion by 2034. This growth is driven by a rising number of pet owners worldwide, a growing inclination toward pet companionship, and a surge in the diagnosis of chronic and infectious diseases in animals. With pet care becoming an integral part of households, spending on veterinary services continues to climb. Pet owners are increasingly treating animals as part of the family, which results in regular health checks, preventive care, and timely diagnosis. This cultural shift has led to a stronger focus on animal wellness, significantly pushing up the demand for advanced diagnostic tools and services.

The market expansion is also underpinned by the increasing awareness of zoonotic diseases and the importance of early diagnosis in avoiding complications. Veterinary professionals are relying more on diagnostics to assess conditions like organ dysfunction, metabolic issues, and infections, which has further fueled the growth of this sector. Moreover, technological advancements are reshaping the landscape by enabling fast, accurate, and less invasive diagnostic techniques. Innovations in veterinary diagnostics are allowing faster turnaround times and better integration with treatment strategies, making diagnostics a critical component of animal healthcare. As veterinary care infrastructure strengthens globally, the demand for diagnostic products and services is expected to remain on an upward trajectory.

In terms of product segmentation, the market is divided into instruments and consumables. In 2024, the consumables segment dominated with a value of USD 2 billion. This dominance is due to the essential role of consumables like reagents, testing kits, slides, and tubes in each diagnostic process. Unlike instruments, consumables are required for every test, resulting in recurring purchases and consistent market revenue. As the frequency of animal testing increases across clinics and hospitals, the demand for consumables is expected to follow suit. The trend toward regular checkups and preventive screenings further boosts usage. Additionally, with more diagnostic procedures moving toward rapid and point-of-care formats, consumables tailored for single-use applications are becoming standard, pushing segmental growth.

When analyzed by application, the bacteriology segment emerged as the leading category in 2024 and is expected to reach USD 2.4 billion by 2034. This segment plays a crucial role in detecting bacterial infections in companion animals, which are commonly seen across a wide range of health conditions. From skin and urinary infections to respiratory and gastrointestinal issues, accurate identification of bacterial pathogens is essential for treatment planning. Modern advancements in bacteriological diagnostics, including improved culturing methods and rapid antigen detection, have significantly elevated diagnostic efficiency. The increasing availability of such technologies at both central labs and point-of-care facilities strengthens the position of bacteriology in the diagnostics landscape.

Based on animal type, the dogs segment led the market with a commanding share of 53.7% in 2024. This dominance is attributed to the widespread ownership of dogs as companion animals and the rising investment in their healthcare. The higher frequency of chronic diseases in dogs has resulted in increased demand for diagnostic tests for conditions such as diabetes, kidney disorders, arthritis, and cardiovascular problems. Routine diagnostics have become essential for disease management in dogs, further driving the demand within this segment.

Regarding end use, diagnostic labs held the largest market share in 2024 and are anticipated to expand at a CAGR of 9.1% from 2025 to 2034. These labs are equipped with high-end diagnostic systems and staffed with trained professionals, allowing them to handle large sample volumes efficiently. Their ability to deliver accurate, quick, and comprehensive results makes them a preferred choice for veterinarians seeking reliable diagnostic support. As the number of pet owners increases and more people opt for regular health assessments for their animals, the role of diagnostic labs becomes even more central.

Regionally, North America led the global companion animal diagnostics market with a value of USD 1 billion in 2024, projected to reach USD 2.3 billion by 2034, growing at a CAGR of 8.8%. The U.S. alone accounted for USD 893.3 million in 2024. High pet ownership rates and the widespread availability of cutting-edge diagnostic services drive demand in the region. Additionally, a strong veterinary healthcare network and rising consumer expenditure on animal wellness continue to bolster market performance in North America.

The competitive landscape is shaped by several global and regional players, with key companies such as IDEXX Laboratories, Thermo Fisher Scientific, Zoetis, and Heska Corporation collectively holding around 60% to 65% of the global market. These firms maintain their leadership through broad product portfolios, geographic reach, and continuous investment in research and development. Alongside them, numerous local players are intensifying competition by offering cost-effective diagnostic solutions and expanding their product lines through partnerships, acquisitions, and new product development.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Technology
  • 2.2.4 Application
  • 2.2.5 Animal type
  • 2.2.6 End use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factors affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing trend of adopting pet animals
    • 3.2.1.2 Rising prevalence of infectious and zoonotic diseases
    • 3.2.1.3 Favorable government initiatives
    • 3.2.1.4 Advancements in companion diagnostics
    • 3.2.1.5 Increasing adoption of pet insurance
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Prohibitive cost associated with animal tests
    • 3.2.2.2 Low out of pocket expenditure on veterinary care
  • 3.2.3 Market opportunities
    • 3.2.3.1 Technological advancements and point-of-care molecular tools
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Consumables
• 5.3 Instruments

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Clinical biochemistry
  • 6.2.1 Glucose monitoring
  • 6.2.2 Blood gas and electrolyte analysis
  • 6.2.3 Other clinical biochemistry tests
• 6.3 Immunodiagnostics
  • 6.3.1 Lateral flow assays
  • 6.3.2 ELISA
  • 6.3.3 Immunoassay analyzers
  • 6.3.4 Other immunodiagnostic tests
• 6.4 Molecular diagnostics
  • 6.4.1 PCR
  • 6.4.2 Microarrays
  • 6.4.3 Other molecular diagnostic tests
• 6.5 Hematology
• 6.6 Urinalysis
• 6.7 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Bacteriology
• 7.3 Pathology
• 7.4 Parasitology
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Dogs
• 8.3 Cats
• 8.4 Horses
• 8.5 Other animal types

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Veterinary hospitals and clinics
• 9.3 Diagnostic labs
• 9.4 Home care settings
• 9.5 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Italy
  • 10.3.5 Spain
  • 10.3.6 Poland
  • 10.3.7 Netherlands
  • 10.3.8 Sweden
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Philippines
  • 10.4.7 Thailand
  • 10.4.8 Indonesia
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
  • 10.5.4 Colombia
  • 10.5.5 Peru
  • 10.5.6 Chile
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE
  • 10.6.4 Turkey
  • 10.6.5 Egypt
  • 10.6.6 Israel

Chapter 11 Company Profiles

• 11.1 bioMerieux
• 11.2 BioNote
• 11.3 Bio-Rad Laboratories
• 11.4 Boehringer Ingelheim International
• 11.5 Heska Corporation (Mars)
• 11.6 Idexx laboratories
• 11.7 KogeneBiotech
• 11.8 Median Diagnostics
• 11.9 Neogen Corporation
• 11.10 Randox
• 11.11 Thermo Fischer Scientific
• 11.12 Virbac
• 11.13 VetAll Laboratories
• 11.14 Qiagen
• 11.15 Zoetis